Characterization and comparison of hypoxia inducing factors on tumor growth and metastasis between two- and three-dimensional cancer models

被引:1
作者
Chan, Leo Li-Ying [1 ]
Kessel, Sarah L. [1 ]
Lin, Bo [1 ]
Juncker-Jensen, Anna [3 ]
Weingarten, Paul [2 ]
机构
[1] Revv Hlth Sci Inc, Lawrence, MA 01843 USA
[2] ImmunityBio, 9920 Jefferson Blva, Culver City, CA 90232 USA
[3] NantBio, Culver City, CA 90232 USA
关键词
IDENTIFIES MCT4; METABOLISM; DYNAMICS; THERAPY; TARGET; GENE;
D O I
10.1016/j.slasd.2023.10.007
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The monocarboxylic acid transporter 4 (Mct-4), a downstream biomarker of hypoxia inducing factor (HIF)-1 alpha, is involved in the cellular response to hypoxia, as indicated by the hypoxic response element in its promoter region. Using a tumorsphere assay as an in vitro 3-dimensional (3D) model generated using 384-well ultralow attachment (ULA) plates for cell proliferation analysis using a plate-based image cytometer, we identify a hypoxic response in the tumorsphere model that is distinct from that of cells grown under 2-dimensional (2D) normoxic conditions and demonstrate a key role for Mct-4 in enabling 3D growth. The tumorsphere model yields evidence of an essential role for Mct-4 in multiple cell lines, which were genetically modified to underexpress and overexpress Mct-4, evidence not apparent in a standard 2D model of growth in the same cell lines. In addition, we identify the effects of overexpressing Mct-4 in cancer cell migration using a transwell chamber assay. We also show that the response to hypoxia may be circumvented by transfection with a CMV promoter driven Mct-4, which confers constitutive 3D growth, wherein tumorsphere growth inhibition by small molecule HIF-1 alpha inhibitors is mitigated. Finally, we demonstrate quantifiable gene/protein expression differences between 2D and 3D cancer models based on the normoxic and hypoxic conditions. Therefore, the tumorsphere 3D model generated using 384-well ULA plates in combination with high-throughput image cytometer is demonstrated to provide a convenient, robust, and reproducible tool and method for the elucidation of mechanisms of action underlying tumor growth and migration in the hypoxic tumor microenvironment.
引用
收藏
页码:59 / 65
页数:7
相关论文
共 17 条
[1]   MCT4 Defines a Glycolytic Subtype of Pancreatic Cancer with Poor Prognosis and Unique Metabolic Dependencies [J].
Baek, GuemHee ;
Tse, Yan F. ;
Hu, Zeping ;
Cox, Derek ;
Buboltz, Noah ;
McCue, Peter ;
Yeo, Charles J. ;
White, Michael A. ;
DeBerardinis, Ralph J. ;
Knudsen, Erik S. ;
Witkiewicz, Agnieszka K. .
CELL REPORTS, 2014, 9 (06) :2233-2249
[2]   Functional screening identifies MCT4 as a key regulator of breast cancer cell metabolism and survival [J].
Baenke, Franziska ;
Dubuis, Sebastien ;
Brault, Charlene ;
Weigelt, Britta ;
Dankworth, Beatrice ;
Griffiths, Beatrice ;
Jiang, Ming ;
Mackay, Alan ;
Saunders, Becky ;
Spencer-Dene, Bradley ;
Ros, Susana ;
Stamp, Gordon ;
Reis-Filho, Jorge S. ;
Howell, Michael ;
Zamboni, Nicola ;
Schulze, Almut .
JOURNAL OF PATHOLOGY, 2015, 237 (02) :152-165
[3]  
Bailey KM, 2012, ADV PHARMACOL, V65, P63, DOI 10.1016/B978-0-12-397927-8.00004-X
[4]   Hypoxia and cancer [J].
Brahimi-Horn, M. Christiane ;
Chiche, Johanna ;
Pouyssegur, Jacques .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2007, 85 (12) :1301-1307
[5]   The MCT4 Gene: A Novel, Potential Target for Therapy of Advanced Prostate Cancer [J].
Choi, Stephen Yiu Chuen ;
Xue, Hui ;
Wu, Rebecca ;
Fazli, Ladan ;
Lin, Dong ;
Collins, Colin C. ;
Gleave, Martin E. ;
Gout, Peter W. ;
Wang, Yuzhuo .
CLINICAL CANCER RESEARCH, 2016, 22 (11) :2721-2733
[6]   BAY 87-2243, a highly potent and selective inhibitor of hypoxia-induced gene activation has antitumor activities by inhibition of mitochondrial complex I [J].
Ellinghaus, Peter ;
Heisler, Iring ;
Unterschemmann, Kerstin ;
Haerter, Michael ;
Beck, Hartmut ;
Greschat, Susanne ;
Ehrmann, Alexander ;
Summer, Holger ;
Flamme, Ingo ;
Oehme, Felix ;
Thierauch, Karlheinz ;
Michels, Martin ;
Hess-Stumpp, Holger ;
Ziegelbauer, Karl .
CANCER MEDICINE, 2013, 2 (05) :611-624
[7]   CRISPR/Cas9-mediated Knockout of SIRT6 Imparts Remarkable Antiproliferative Response in Human Melanoma Cellsin vitroandin vivo [J].
Garcia-Peterson, Liz M. ;
Ndiaye, Mary A. ;
Chhabra, Gagan ;
Singh, Chandra K. ;
Guzman-Perez, Glorimar ;
Iczkowski, Kenneth A. ;
Ahmad, Nihal .
PHOTOCHEMISTRY AND PHOTOBIOLOGY, 2020, 96 (06) :1314-1320
[8]   Genome-wide RNA interference analysis of renal carcinoma survival regulators identifies MCT4 as a Warburg effect metabolic target [J].
Gerlinger, Marco ;
Santos, Claudio R. ;
Spencer-Dene, Bradley ;
Martinez, Pierre ;
Endesfelder, David ;
Burrell, Rebecca A. ;
Vetter, Marcus ;
Jiang, Ming ;
Saunders, Rebecca E. ;
Kelly, Gavin ;
Dykema, Karl ;
Rioux-Leclercq, Nathalie ;
Stamp, Gordon ;
Patard, Jean Jacques ;
Larkin, James ;
Howell, Michael ;
Swanton, Charles .
JOURNAL OF PATHOLOGY, 2012, 227 (02) :146-156
[9]   Evolutionary dynamics of carcinogenesis and why targeted therapy does not work [J].
Gillies, Robert J. ;
Verduzco, Daniel ;
Gatenby, Robert A. .
NATURE REVIEWS CANCER, 2012, 12 (07) :487-493
[10]   Hallmarks of Cancer: The Next Generation [J].
Hanahan, Douglas ;
Weinberg, Robert A. .
CELL, 2011, 144 (05) :646-674